Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia

[1]  Dagmar Hartge,et al.  Report , 2019, Datenschutz und Datensicherheit - DuD.

[2]  C. Horsburgh,et al.  Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay. , 2019, The International Journal of Tuberculosis and Lung Disease.

[3]  J. Tripathy,et al.  The clinical utility of cycle of threshold value of GeneXpert MTB/RIF (CBNAAT) and its diagnostic accuracy in pulmonary and extra-pulmonary samples at a tertiary care center in India. , 2018, The Indian journal of tuberculosis.

[4]  Abdurahaman Seid,et al.  Assessment of Extrapulmonary Tuberculosis Using Gene Xpert MTB/RIF Assay and Fluorescent Microscopy and Its Risk Factors at Dessie Referral Hospital, Northeast Ethiopia , 2018, BioMed research international.

[5]  C. Horsburgh,et al.  Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  E. Ejeta,et al.  Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high Human Immunodeficiency Virus setting in Gambella regional state, southwest Ethiopia , 2018, Journal of clinical tuberculosis and other mycobacterial diseases.

[7]  Mebrahtu Teweldemedhin,et al.  Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Systematic Review , 2018, Journal of pathogens.

[8]  G. Cavallini,et al.  Anterior Capsule of the Lens: Comparison of Morphological Properties and Apoptosis Induction following FLACS and Standard Phacoemulsification Surgery , 2018, BioMed research international.

[9]  G. Alvarez-Uria,et al.  Molecular Epidemiology of Rifampicin Resistance in Mycobacterium tuberculosis Using the GeneXpert MTB/RIF Assay from a Rural Setting in India , 2017, Journal of pathogens.

[10]  N. Dendukuri,et al.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance , 2017, The Cochrane database of systematic reviews.

[11]  A. Onyeabor,et al.  Comparative Response of the Nigerian Indigenous and Broiler Chickens to a Field Caecal Isolate of Eimeria Oocysts , 2017, Journal of pathogens.

[12]  I. Hoffman,et al.  Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi , 2017, African journal of laboratory medicine.

[13]  Wondemagegn Mulu,et al.  Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study , 2017, BMC Research Notes.

[14]  Richard G. White,et al.  Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis , 2016, PLoS medicine.

[15]  I. Ullah,et al.  Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study , 2016, BMC Infectious Diseases.

[16]  Ramandeep Kaur,et al.  Epidemiology of Rifampicin Resistant Tuberculosis and Common Mutations in rpoB Gene of Mycobacterium tuberculosis: A Retrospective Study from Six Districts of Punjab (India) Using Xpert MTB/RIF Assay , 2016, Journal of laboratory physicians.

[17]  R. Kaul,et al.  Cholecystitis Associated with Heterotopic Pancreas, Pseudopyloric Metaplasia, and Adenomyomatous Hyperplasia: A Rare Combination , 2016, Journal of laboratory physicians.

[18]  J. Pape,et al.  False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. , 2016, Diagnostic microbiology and infectious disease.

[19]  S. Afrin,et al.  Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis , 2016, PloS one.

[20]  Gemeda Abebe,et al.  Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia , 2016, International journal of mycobacteriology.

[21]  M. Meremikwu,et al.  Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria , 2016, International journal of mycobacteriology.

[22]  L. Rigouts,et al.  GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings , 2015, PloS one.

[23]  T. Mustafa,et al.  Laboratory Diagnosis of Extra-pulmonary Tuberculosis (EPTB) in Resource-constrained Setting: State of the Art, Challenges and the Need. , 2015, Journal of clinical and diagnostic research : JCDR.

[24]  W. Ssengooba,et al.  Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert®MTB/RIF in Kampala, Uganda: a retrospective study , 2014, BMC Infectious Diseases.

[25]  U. Sack,et al.  Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia. , 2013, International journal of medical sciences.

[26]  S. Lawn,et al.  Diagnosis of extrapulmonary tuberculosis using the Xpert® MTB/RIF assay , 2012, Expert review of anti-infective therapy.

[27]  Frank Emmrich,et al.  Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia , 2012, BMC Infectious Diseases.

[28]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[29]  F. Biadglegne,et al.  Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and its Rifampicin resistance at Felege Hiwot and Debre Tabor Hospitals, Northwest Ethiopia: A preliminary implementation research , 2016 .

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..